Similar articles

• Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells.

  Rickinson AB, Finerty S, Epstein MA. Rickinson AB, et al. Clin Exp Immunol. 1982 Nov;50(2):347-54. Clin Exp Immunol. 1982. PMID: 6295671 Free PMC article.
• Epstein-barr virus-negative human malignant T-cell lines.

  Kaplan J, Shope TC, Peterson WD Jr. Kaplan J, et al. J Exp Med. 1974 May 1;139(5):1070-6. doi: 10.1084/jem.139.5.1070. J Exp Med. 1974. PMID: 4363409 Free PMC article.
• Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.

  Greaves MF, Brown G. Greaves MF, et al. Clin Immunol Immunopathol. 1975 Mar;3(4):514-24. doi: 10.1016/0090-1229(75)90076-8. Clin Immunol Immunopathol. 1975. PMID: 163715 No abstract available.
• Acute leukemia: the use of surface markers in classification.

  Humphrey GB, Lankford J. Humphrey GB, et al. Semin Oncol. 1976 Sep;3(3):243-51. Semin Oncol. 1976. PMID: 185724 Review. No abstract available.
• Oncogenic DNA viruses of nonhuman primates: a review.

  Falk LA. Falk LA. Lab Anim Sci. 1974 Feb;24(1):182-92. Lab Anim Sci. 1974. PMID: 4366130 Review. No abstract available.